Back

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus

17 April 2023 (15:40 - 16:40)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 6 - Mechanisms - Pathophysiology Heart Failure in Atrial Fibrillation EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Young Choi

Seoul St. Marys Hospital, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Associations of general and abdominal obesity, and genetic risk with atrial fibrillation: longitudinal analyses in the UK biobank study
Doctor S. Choi (Seoul, KR)
Abstract Slides
Presentation thumbnail
Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF
Doctor Y. Prudat (Lausanne, CH) Doctor P. Pascale (Lausanne, CH)
Abstract
Presentation thumbnail
Volumetric quantification of peri-atrial fat inflammation in atrial fibrillation patients
Doctor K. Vickneson (Edinburgh, GB)
Abstract Slides
Presentation thumbnail
Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers
Mrs R. Al-Shama (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides

Access the full session

Session thumbnail
Atrial Fibrillation - Round 6 - Mechanisms - Pathophysiology

The Event

Event poster

EHRA 2023

17 April 2023 15:40 CET